ici 118551 has been researched along with transforming growth factor beta in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, PJ; Haddad, EB; Mak, JC; Rousell, J | 1 |
Lu, J; Lu, X; Luo, H; Pu, J; Xu, L; Zhang, X | 1 |
2 other study(ies) available for ici 118551 and transforming growth factor beta
Article | Year |
---|---|
Transforming growth factor-beta1 inhibits beta2-adrenoceptor gene transcription.
Topics: Adrenergic beta-Antagonists; Binding Sites; Binding, Competitive; Blotting, Northern; Cell Line; Cyclic AMP; Down-Regulation; Embryo, Mammalian; Fibroblasts; Gene Expression; Humans; Imidazoles; Iodine Radioisotopes; Kinetics; Lung; Pindolol; Propanolamines; Radioligand Assay; Receptors, Adrenergic, beta-2; RNA, Messenger; Transcription, Genetic; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2000 |
Adrenaline promotes epithelial-to-mesenchymal transition via HuR-TGFβ regulatory axis in pancreatic cancer cells and the implication in cancer prognosis.
Topics: Adrenergic beta-Antagonists; Aged; Cell Line, Tumor; Cell Movement; ELAV-Like Protein 1; Epinephrine; Epithelial-Mesenchymal Transition; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Pancreatic Neoplasms; Propanolamines; Receptors, Adrenergic, beta-2; Transforming Growth Factor beta | 2017 |